Skip to Content
Merck
CN

C61208

2-Chloro-4-nitrophenol

97%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
ClC6H3(NO2)OH
CAS Number:
Molecular Weight:
173.55
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
210-578-8
MDL number:
Assay:
97%
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

97%

form

powder

mp

105-106 °C (lit.)

SMILES string

Oc1ccc(cc1Cl)[N+]([O-])=O

InChI

1S/C6H4ClNO3/c7-5-3-4(8(10)11)1-2-6(5)9/h1-3,9H

InChI key

BOFRXDMCQRTGII-UHFFFAOYSA-N



pictograms

Exclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Hassan Sakhtah et al.
Applied and environmental microbiology, 85(14) (2019-05-06)
The yeast Kluyveromyces lactis has been a successful host for the production of heterologous proteins for over 30 years. Currently, the galactose-/lactose-inducible and glucose-repressible LAC4 promoter (P
Tangrong Liu et al.
Analytical and bioanalytical chemistry, 411(7), 1467-1477 (2019-02-02)
α-L-Fucosidase (AFU) is a promising therapeutic target for the treatment of inflammation, cancer, cystic fibrosis, and fucosidosis. Some of the existing analytical methods for the assessment of AFU activity are lacking in sensitivity and selectivity, since most of them are
Y A Soushko et al.
Revue de laryngologie - otologie - rhinologie, 114(1), 59-61 (1993-01-01)
In vitro experiments, Terrilytinum* increases the antimycotic activity of Clotrimazolum* and Nitrofungin*, and cancels out the inhibitory effect of Contrycal*. The combined application of Clotrimazolum and Nitrofungin with Terrilytinum and Contrycal as treatment of otomycosis of the middle ear has



Global Trade Item Number

SKUGTIN
C61208-50G04061833503652
C61208-10G04061833503638